Lipo-Dox
AmBiL
Doxisome
ProFlow
TLCx99
Lipotecan
 
  The lipid-based technology platforms enabled TLC to develop a series of super generic drugs and New Chemical Entities
 
 
PROVEN DRUG NEW DRUG
PROVEN Delivery Techonology New Delivery Techonology PROVEN Delivery Techonology NEW Delivery Techonology
Lipo-Dox AmBiL Doxisome ProFlow TLCx99 Lipotecan
Increasing potential value-added & increasing mutlplied risk